Author

S. C. Callahan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Assay:ChIP-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

J. Schulz· 3 shared K. Rai· 3 shared M. Tang· 3 shared A. K. Singh· 2 shared A. T. Raman· 2 shared E. Arslan· 2 shared J. N. Myers· 2 shared M. Divenko· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

J. Schulz

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

KMT2D Loss Promotes Head and Neck Squamous Cell Carcinoma Through Enhancer Reprogramming and Modulation of Immune Microenvironment

S. C. Callahan, M. Divenko, P. Barrodia, A. K. Singh, E. Arslan, Z. Liu, J. Yang, N. Anvar, M. Amit, T. Xie, S. Jiang, J. Schulz, M. Tang, J. N. Myers, K. Rai

This study shows KMT2D loss in HNSCC leads to enhancer reprogramming and immune microenvironment changes, promoting tumor growth through interferon signaling disruption.

bioRxiv · Sep 21, 2021 · PreprintCancer Biology

High Enhancer Activity is an Epigenetic Feature of HPV Negative Atypical Head and Neck Squamous Cell Carcinoma

S. C. Callahan, V. Kochat, Z. Liu, A. T. Raman, J. Schulz, C. Terranova, M. Divenko, A. Ghosh, M. Tang, C. Pickering, J. N. Myers, K. Rai

The paper identifies high enhancer activity in HPV-negative atypical HNSCC as linked to BET inhibitor resistance and upregulated signaling pathways.

bioRxiv · Sep 21, 2021Cancer Biology

Chromatin State Dynamics Confers Specific Therapeutic Strategies in Enhancer Subtypes of Colorectal Cancer

E. Orouji, A. T. Raman, A. K. Singh, A. Sorokin, E. Arslan, A. K. Ghosh, J. Schulz, C. J. Terranova, M. Tang, M. Maitituoheti, S. C. Callahan, K. J. Tomczak, Z. Jiang, J. S. Davis, S. Ghosh, , K. Rai

This study identifies enhancer subtypes in colorectal cancer through epigenomic analysis and proposes targeted therapeutic strategies based on these subtypes.

bioRxiv · Sep 4, 2020Cancer Biology